Old Web
English
Sign In
Acemap
>
Paper
>
Epidoxorubicin (EPI-DX) and lonidamine (LND) in refractory or recurrent epithelial ovarian cancer (EOC)
Epidoxorubicin (EPI-DX) and lonidamine (LND) in refractory or recurrent epithelial ovarian cancer (EOC)
1994
I. Brunetti
Pg Giannessi
DArgenio
Angiolo Gadducci
Pf Conte
Keywords:
Ovarian cancer
Molecular biology
Medicine
Cancer research
Oncology
Lonidamine
Internal medicine
epithelial ovarian cancer
Refractory
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]